HUM-MOLGEN events: How to Better Optimize an Oncology Drug Discovery Program

Speakers

Olivier Duchamp, Head of in vivo sciences, Oncodesign Service Business Unit at Oncodesign

Olivier Duchamp is the head of the In Vivo Sciences Department at Oncodesign BU Service. He was at the founding of the company and for the last 26 years, contributed largely to its development and innovation in preclinical models and pharmaco-imaging. He holds a bachelor’s degree from the University of Lyon (France) and a master’s degree in pharmacology and analytical methods from the University of Paris IV (France).

Olivier is also the coordinator of IMODI, (Innovative MODels Initiative), a French consortium dedicated to the development, the characterization and the commercialization of new preclinical models in oncology, including PDX models and humanized mouse models. He is the co-author of several publications about PDX models.

Message Presenter

http://Jean-François%20Mirjolet,%20Oncodesign

Jean-François Mirjolet, Head of in vitro sciences, Oncodesign Service Business Unit at Oncodesign

Jean-François Mirjolet is the head of the in vitro Sciences Department at Oncodesign BU Service. He has been working for Oncodesign for 17 years, going through various positions from study director, technology director to his current role, managing both services and R&D related in vitro activities.

He obtained his PhD from the University of Nancy (France) in cellular pharmacology of anticancer drugs, followed by post-doctoral position at the IRIBHM, Brussels (Belgium) in chemokines and chemokine receptors implication in cancer cell migration.